- Home
- SXTC vs MULN Comparison
SXTC vs MULN Comparison
Compare SXTC & MULN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTC
- MULN
- Stock Information
- Founded
- SXTC 2005
- MULN 2014
- Country
- SXTC China
- MULN United States
- Employees
- SXTC N/A
- MULN N/A
- Industry
- SXTC Biotechnology: Pharmaceutical Preparations
- MULN Auto Manufacturing
- Sector
- SXTC Health Care
- MULN Consumer Discretionary
- Exchange
- SXTC Nasdaq
- MULN Nasdaq
- Market Cap
- SXTC 977.1K
- MULN N/A
- IPO Year
- SXTC 2019
- MULN N/A
- Fundamental
- Price
- SXTC $0.73
- MULN $2.48
- Analyst Decision
- SXTC
- MULN
- Analyst Count
- SXTC 0
- MULN 0
- Target Price
- SXTC N/A
- MULN N/A
- AVG Volume (30 Days)
- SXTC 1.4M
- MULN 1.9M
- Earning Date
- SXTC 01-01-0001
- MULN 08-12-2024
- Dividend Yield
- SXTC N/A
- MULN N/A
- EPS Growth
- SXTC N/A
- MULN N/A
- EPS
- SXTC N/A
- MULN N/A
- Revenue
- SXTC $1,928,497.00
- MULN $156,570.00
- Revenue This Year
- SXTC N/A
- MULN N/A
- Revenue Next Year
- SXTC N/A
- MULN N/A
- P/E Ratio
- SXTC N/A
- MULN N/A
- Revenue Growth
- SXTC N/A
- MULN N/A
- 52 Week Low
- SXTC $0.53
- MULN $2.41
- 52 Week High
- SXTC $6.39
- MULN $4,900.00
- Technical
- Relative Strength Index (RSI)
- SXTC 51.89
- MULN 17.73
- Support Level
- SXTC $0.65
- MULN $24.00
- Resistance Level
- SXTC $0.82
- MULN $3.97
- Average True Range (ATR)
- SXTC 0.09
- MULN 1.32
- MACD
- SXTC 0.03
- MULN 2.54
- Stochastic Oscillator
- SXTC 58.69
- MULN 0.61
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, Advanced TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates a majority of its revenue from the People's Republic of China.